Policy | March 16, 2023
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Expands robotics to 20+ specialities
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
A funding to expand operations and provide better patient care
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The inspection concluded with no observations
Subscribe To Our Newsletter & Stay Updated
